Opicapone
Back to searchMolecule Structure
Scientific Name
Opicapone
Description of the Drug
Opicapone is a catechol-O-methyltransferase inhibitor used as an adjunct treatment for Parkinson’s Disease in adults currently receiving levodopa and a dopa decarboxylase inhibitor.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11632
http://www.drugbank.ca/drugs/DB11632
Brand Name(s)
Ongentys
Company Owner(s)
Neurocrine Biosciences Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Catechol O-methyltransferase | SINGLE PROTEIN | INHIBITOR | CHEMBL2023 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL539065 | |
| Human Metabolome Database | HMDB0304860 | |
| DrugBank | DB11632 | |
| PubChem: Thomson Pharma | 21959745 | |
| PubChem | 135565903 | |
| BindingDB | 50019329 | |
| DrugCentral | 5143 | |
| rxnorm | ONGENTYS | OPICAPONE |
| ChEBI | 134699 | |
| ZINC | ZINC000034602275 |
